SEC 13F Intelligence

Epoch Investment Partners, Inc. / WST

Epoch Investment Partners, Inc.’s West Pharmaceutical Svsc Inc Position

Does Epoch Investment Partners, Inc. own West Pharmaceutical Svsc Inc (WST)? Yes545.0K shares worth $137M (+0.83% of its 13F portfolio) as of Q1 2026, up from 505.3K shares the prior filed quarter.

Position Value
$137M
Q1 2026
Shares
545.0K
% of Portfolio
+0.83%
Quarters Held
23
currently held

Position History WST

Reported value by quarter
Q3 ’20: $13MQ3 ’20Q4 ’20: $14MQ1 ’21: $14MQ2 ’21: $19MQ2 ’21Q3 ’21: $23MQ4 ’21: $25MQ1 ’22: $29MQ1 ’22Q2 ’22: $22MQ3 ’22: $18MQ4 ’22: $32MQ4 ’22Q1 ’23: $47MQ2 ’23: $50MQ3 ’23: $47MQ3 ’23Q4 ’23: $79MQ1 ’24: $103MQ2 ’24: $89MQ2 ’24Q3 ’24: $79MQ4 ’24: $89MQ1 ’25: $74MQ1 ’25Q2 ’25: $79MQ3 ’25: $138MQ4 ’25: $139MQ4 ’25Q1 ’26: $137Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026545.0K$137M+0.83%
Q4 2025505.3K$139M+0.79%
Q3 2025525.9K$138M+0.76%
Q2 2025361.3K$79M+0.41%
Q1 2025329.8K$74M+0.38%
Q4 2024272.5K$89M+0.43%
Q3 2024262.5K$79M+0.35%
Q2 2024269.7K$89M+0.41%
Q1 2024260.5K$103M+0.46%
Q4 2023223.5K$79M+0.36%
Q3 2023124.4K$47M+0.30%
Q2 2023131.6K$50M+0.29%
Q1 2023134.4K$47M+0.28%
Q4 2022136.2K$32M+0.19%
Q3 202273.0K$18M+0.12%
Q2 202272.3K$22M+0.13%
Q1 202271.5K$29M+0.14%
Q4 202152.8K$25M+0.13%
Q3 202153.2K$23M+0.13%
Q2 202151.6K$19M+0.10%
Q1 202150.7K$14M+0.07%
Q4 202050.8K$14M+0.07%
Q3 202049.0K$13M+0.07%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Epoch Investment Partners, Inc.’s full portfolio or all institutional holders of WST.